Soy Protein Supplement In Treating Hot Flashes in Postmenopausal Women Receiving Tamoxifen for Breast Disease
Study Information
Alliance Study ID: CALGB-79805
NCT Study ID (ClinicalTrials.gov): NCT00031720
Alliance Committee: Cancer Control
Disease or Cancer Type: Breast Cancer
Alliance Study Chair: Gini F. Fleming, MD
Status: COMPLETED
Study Description
RATIONALE: Soy protein supplement may be effective in reducing hot flushes in postmenopausal women who are receiving tamoxifen for breast disease.
PURPOSE: Randomized phase II trial to determine the effectiveness of soy protein supplement in reducing hot flushes in postmenopausal women who are receiving tamoxifen for breast disease such as ductal hyperplasia or breast cancer.
Related Publications
For publications related to this and other clinical trials, visit the Alliance Publications Application.
Data Sources & Contacts
Full trial details
For more Information